To further determine the cancer cell-intrinsic and PI3K activation-dependent immune modulating effects, we analyzed the RNAseq date from CAP2/CAP8/PC3 cell lines with two criteria: gene expressions were upregulated upon 48 h BAY1082439 treatment and downregulated 72 h after BAY1082439 withdrawal. Here, CAP2 is linked to cancer.